Evidence map›Paper›PMID 19339764›Full record

ReviewThe Journal of clinical investigation2009

Bipolar disorder: from genes to behavior pathways.

Keri Martinowich, Robert J Schloesser, Husseini K Manji

Abstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Antimanic Efficacy of a Novel Kv3 Potassium Channel Modulator.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Keri MartinowichJohnson & Johnson Pharmaceutical Research and Development, 1125 Trenton-Harbourton Road, E32000, Titusville, New Jersey 08560, USA. hmanji@its.jnj.com
Robert J Schloesser
Husseini K Manji

Funding

Role of the p75NTR, LTD and the cholinergic system in mediating coping mechanismZIAMH002910 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI HERKENHAM, MILES A. · 2009 to 2012
$1.3M
Role of the p75NTR, LTD and the cholinergic system in mediating coping mechanismZ01MH002910 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI MANJI, HUSSEINI · 2008 to 2008
$550k
6 · The paper itself

Abstract

Bipolar disorder (BPD) is a devastating illness that is characterized by recurrent episodes of mania and depression. In addition to these cyclic episodes, individuals with BPD exhibit changes in psychovegetative function, cognitive performance, and general health and well being. In this article we draw from neuroimaging findings in humans, postmortem data, and human genetic and pharmacological studies as well as data from animal models of behavior to discuss the neurobiology of BPD. We conclude with a synthesis of where the field stands and with suggestions and strategies for future areas of study to further increase our conceptual understanding of this complex illness.

Indexed as

AnimalsBehaviorBipolar DisorderBrainDisease Models, AnimalGenetic EngineeringHumansMiceModels, NeurologicalNeural PathwaysSignal Transduction

Identifiers

PMID19339764
PMCPMC2662565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.